APP下载

益气化痰颗粒联合羧甲司坦减少慢性阻塞性肺疾病急性加重临床研究

2015-05-30高峰等

中国中医药信息杂志 2015年8期
关键词:慢性阻塞性肺疾病

高峰等

摘要:目的 观察益气化痰颗粒联合羧甲司坦减少慢性阻塞性肺疾病(COPD)稳定期患者急性加重的疗效及安全性。方法 纳入COPD稳定期气虚或兼痰阻/血瘀证患者108例,采用区组随机法分为观察组和对照组各54例。对照组口服羧甲司坦并按需吸入支气管舒张剂,观察组在此基础上联合益气化痰颗粒冲服,疗程24周。观察2组治疗期间COPD急性加重次数与程度及治疗前后中医证候评分、肺功能、6 min步行距离变化。结果 观察组平均急性加重总次数(0.33±0.55)低于对照组(0.62±0.71),平均重度急性加重次数(0.12±0.33)低于对照组(0.28±0.45),差异均有统计学意义(P<0.05);治疗前后症状评分比较,观察组中医证候总分、喘息/呼吸困难评分、气短乏力评分及6 min步行距离的改善均优于对照组(P<0.05);治疗安全性好。结论 益气化痰颗粒联合羧甲司坦治疗COPD稳定期患者,可有效减少COPD急性加重的次数及程度,改善患者中医证候评分及6 min步行距离。

关键词:益气化痰颗粒;慢性阻塞性肺疾病;急性加重;中西医结合疗法

DOI:10.3969/j.issn.1005-5304.2015.08.012

中图分类号:R259.639 文献标识码:A 文章编号:1005-5304(2015)08-0043-04

Clinical Study of Yiqi Huatan Granules Combined with Carbocisteine to Reduce Acute Exacerbation of Chronic Obstructive Pulmonary Disease GAO Feng, WU Wei, WANG Bin, WANG Wei, ZHANG Li-chun, LI Shan (Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China)

Abstract:Objective To observe the efficacy and safety of Yiqi Huatan Granules combined with carbocisteine to reduce the acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods Totally 108 patients in the stationary phase of COPD with qi deficiency or merging phlegm blockage/blood stasis syndrome were randomly divided into two groups. Patients in the control group were treated with carbocisteine and inhaled bronchodilators on-demand, while patients in the treatment group were treated with Yiqi Huatan Granules combined with carbocisteine and bronchodilators for 24 weeks. Times and severity of acute exacerbations of COPD, TCM syndrome scores, lung function, and 6-minute walking distances of the two groups during the treatment period were observed. Results The average times of acute exacerbations of COPD in the treatment group (0.33 ± 0.55) were fewer than the control group (0.62 ± 0.71);the average times of severe acute exacerbations of COPD in the treatment group (0.12 ± 0.33) were fewer than the control group (0.28 ± 0.45), with statistical significance (P<0.05). Comparison between the TCM syndrome scores before and after treatment, TCM total syndrome scores, breathless/dyspnea score, breath shortness and fatigue score, and 6-minute walking distance in the treatment group were better than the control group (P<0.05), with better safety. Conclusion The treatment of Yiqi Huatan Granules combined with carbocisteine for COPD patients can effectively decrease times and severity of acute exacerbations of COPD, and improve TCM syndrome scores and 6-minute walking distance.

Key words:Yiqi Huatan Granules;chronic obstructive pulmonary disease;acute exacerbation;integration of traditional Chinese medicine and Western medicine

基金项目:北京市中医药科技发展基金项目(JJ2011-74)

慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是一种可以预防和治疗的常见疾病,其特征是持续存在的气流受限。气流受限呈进行性发展,伴有气道和肺对有害颗粒或气体所致慢性炎症反应的增加。急性加重和合并症影响患者整体疾病的严重程度[1]。减少COPD急性加重、改善预后已成为目前临床研究的重点。本研究观察益气化痰颗粒联合羧甲司坦减少COPD急性加重发生的疗效,现报道如下。

1 临床资料

1.1 一般资料

病例来自2012年3月-2013年10月于本院呼吸科就诊的COPD稳定期患者。采用SPSS16.0软件进行区组随机分组,按1∶1比例,将108例入选患者按照入组先后顺序查表,分为观察组和对照组各54例。因入组后复查肺功能排除COPD诊断或入组后未接受治疗,剔除4例(观察组3例,对照组1例),实际统计病例104例。……

登录APP查看全文

猜你喜欢

慢性阻塞性肺疾病
代赭石降气平喘作用的临床验证观察
布地奈德/福莫特罗粉剂联合噻托溴铵治疗稳定期慢阻肺的疗效探究
慢性阻塞性肺疾病合并支气管扩张的临床诊治分析
多索茶碱与噻托溴铵联合治疗对慢性阻塞性肺疾病肺功能的影响
有创后序贯无创机械通气治疗慢性阻塞性肺疾病合并严重呼吸衰竭的临床分析
无创正压通气联合参麦注射液治疗COPD并呼吸衰竭的临床效果
多元性护理干预对慢性阻塞性肺疾病长期家庭氧疗依从性的应用价值
无创机械通气联合盐酸氨溴索雾化治疗慢性阻塞性肺疾病伴Ⅱ型呼吸衰竭的效果分析
授权理论在使用无创呼吸机COPD患者健康教育中的应用